WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muñoz, F. J.
Right arrow Articles by Inestrosa, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muñoz, F. J.
Right arrow Articles by Inestrosa, N. C.

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 15, 2002, 22(8):3081-3089

Vitamin E But Not 17beta -Estradiol Protects against Vascular Toxicity Induced by beta -Amyloid Wild Type and the Dutch Amyloid Variant

Francisco J. Muñoz1, Carlos Opazo4, Gabriel Gil-Gómez2, Gladys Tapia3, Virginia Fernández3, Miguel A. Valverde1, and Nibaldo C. Inestrosa4

1 Unitat de Senyalització Cel·lular, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona E-08003, Spain, 2 Institut Municipal d'Investigació Mèdica (Universitat Pompeu Fabra), Barcelona E-08003, Spain, 3 Programa de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile, and 4 Centro de Regulación Celular y Patología, Fondo de Investigación Avanzada en Áreas Prioritarias-Biomedicina and Millenium Institute for Fundamental and Applied Biology, Pontificia Universidad Católica de Chile, Santiago, Chile

Amyloid beta -peptide (Abeta ) fibril deposition on cerebral vessels produces cerebral amyloid angiopathy that appears in the majority of Alzheimer's disease patients. An early onset of a cerebral amyloid angiopathy variant called hereditary cerebral hemorrhage with amyloidosis of the Dutch type is caused by a point mutation in Abeta yielding Abeta Glu22right-arrow Gln. The present study addresses the effect of amyloid fibrils from both wild-type and mutated Abeta on vascular cells, as well as the putative protective role of antioxidants on amyloid angiopathy. For this purpose, we studied the cytotoxicity induced by Abeta 1-40 Glu22right-arrow Gln and Abeta 1-40 wild-type fibrils on human venule endothelial cells and rat aorta smooth muscle cells. We observed that Abeta Glu22right-arrow Gln fibrils are more toxic for vascular cells than the wild-type fibrils. We also evaluated the cytotoxicity of Abeta fibrils bound with acetylcholinesterase (AChE), a common component of amyloid deposits. Abeta 1-40 wild-type-AChE fibrillar complexes, similar to neuronal cells, resulted in an increased toxicity on vascular cells. Previous reports showing that antioxidants are able to reduce the toxicity of Abeta fibrils on neuronal cells prompted us to test the effect of vitamin E, vitamin C, and 17beta -estradiol on vascular damage induced by Abeta wild-type and Abeta Glu22right-arrow Gln. Our data indicate that vitamin E attenuated significantly the Abeta -mediated cytotoxicity on vascular cells, although 17beta -estradiol and vitamin C failed to inhibit the cytotoxicity induced by Abeta fibrils.

Key words: Alzheimer's disease; CAA; HCHWA-D; amyloid; vitamin E; 17beta -estradiol; vitamin C; oxidative stress; acetylcholinesterase; endothelial cells; vascular smooth muscle cells


Copyright © 2002 Society for Neuroscience  0270-6474/02/2283081-09$05.00/0


This article has been cited by other articles:


Home page
J. Neurosci.Home page
B. H. Han, M.-l. Zhou, F. Abousaleh, R. P. Brendza, H. H. Dietrich, J. Koenigsknecht-Talboo, J. R. Cirrito, E. Milner, D. M. Holtzman, and G. J. Zipfel
Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-{beta} Peptide, Partial Restoration via {gamma}-Secretase Inhibition
J. Neurosci., December 10, 2008; 28(50): 13542 - 13550.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. Coma, F. X. Guix, I. Uribesalgo, G. Espuna, M. Sole, D. Andreu, and F. J. Munoz
Lack of oestrogen protection in amyloid-mediated endothelial damage due to protein nitrotyrosination
Brain, July 1, 2005; 128(7): 1613 - 1621.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Quintanilla, F. J. Munoz, M. J. Metcalfe, M. Hitschfeld, G. Olivares, J. A. Godoy, and N. C. Inestrosa
Trolox and 17{beta}-Estradiol Protect against Amyloid {beta}-Peptide Neurotoxicity by a Mechanism That Involves Modulation of the Wnt Signaling Pathway
J. Biol. Chem., March 25, 2005; 280(12): 11615 - 11625.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. E. Reyes, M. A. Chacon, M. C. Dinamarca, W. Cerpa, C. Morgan, and N. C. Inestrosa
Acetylcholinesterase-A{beta} Complexes Are More Toxic than A{beta} Fibrils in Rat Hippocampus: Effect on Rat {beta}-Amyloid Aggregation, Laminin Expression, Reactive Astrocytosis, and Neuronal Cell Loss
Am. J. Pathol., June 1, 2004; 164(6): 2163 - 2174.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. A. Moss, M. R. Nichols, D. K. Reed, J. H. Hoh, and T. L. Rosenberry
The Peptide KLVFF-K6 Promotes {beta}-Amyloid(1-40) Protofibril Growth by Association but Does Not Alter Protofibril Effects on Cellular Reduction of 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT)
Mol. Pharmacol., November 1, 2003; 64(5): 1160 - 1168.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-